Alberta Stroke Program Early CT Score Infarct Location Predicts Outcome Following M2 Occlusion by Muhib Khan et al.
March 2017 | Volume 8 | Article 981
Original research
published: 14 March 2017
doi: 10.3389/fneur.2017.00098
Frontiers in Neurology | www.frontiersin.org
Edited by: 
Jean-Claude Baron, 
Université Paris Descartes, France
Reviewed by: 
Daniel Strbian, 
Helsinki University Hospital, Finland 
Alexander Tsiskaridze, 
Tbilisi State University, Georgia
*Correspondence:
Muhib Khan 
muhib.khan@spectrumhealth.org
Specialty section: 
This article was submitted to Stroke, 
a section of the journal 
Frontiers in Neurology
Received: 01 November 2016
Accepted: 28 February 2017
Published: 14 March 2017
Citation: 
Khan M, Baird GL, Goddeau RP Jr., 
Silver B and Henninger N (2017) 
Alberta Stroke Program Early 
CT Score Infarct Location Predicts 
Outcome Following M2 Occlusion. 
Front. Neurol. 8:98. 
doi: 10.3389/fneur.2017.00098
alberta stroke Program early 
cT score infarct location Predicts 
Outcome Following M2 Occlusion
Muhib Khan1,2*, Grayson L. Baird3, Richard P. Goddeau Jr.4, Brian Silver5 and  
Nils Henninger4,6
1 Neuroscience Institute, Division of Neurology, Spectrum Health, Grand Rapids, MI, USA, 2 Michigan State University College 
of Human Medicine, Grand Rapids, MI, USA, 3 Lifespan Biostatistics Core, Rhode Island Hospital, Providence, RI, USA, 
4 Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA, 5 Department of Neurology, 
Warren Alpert Medical School of Brown University, Providence, RI, USA, 6 Department of Psychiatry, University of 
Massachusetts Medical School, Worcester, MA, USA
Background: Although it is generally thought that patients with distal middle cerebral 
artery (M2) occlusion have a favorable outcome, it has previously been demonstrated 
that a substantial minority will have a poor outcome by 90 days. We sought to determine 
whether assessing the Alberta Stroke Program Early CT Score (ASPECTS) infarct loca-
tion allows for identifying patients at risk for a poor 90-day outcome.
Methods: We retrospectively analyzed patients with isolated acute M2 occlusion admit-
ted to a single academic center between January 2010 and August 2012. Infarct regions 
were defined according to ASPECTS system on the initial head computed tomography. 
Discriminant function analysis was used to define specific ASPECTS regions that are 
predictive of the 90-day functional outcome as defined as a modified Rankin Scale score 
of 3–6. In addition, logistic regression was used to model the relationship between each 
individual ASPECT region with poor outcome; for evaluation and comparison, odds 
ratios, c-statistics, and Akaike information criterion values were estimated for each 
region.
results: Ninety patients with isolated M2 were included in the final analysis. ASPECTS 
score ≤6 predicted poor outcome in this cohort (sensitivity = 0.591, specificity = 0.838, 
p < 0.001). Using multiple approaches, we found that infarction in ASPECTS regions M3 
and M6 were strongly associated with poor functional status by 90 days.
conclusion: Infarction in ASPECTS regions M3 and M6 are key predictors of functional 
outcome following isolated distal M2 occlusion. These findings will be helpful in stratifying 
outcomes if validated in future studies.
Keywords: M2 occlusions, outcome, alberta stroke Program early cT score, stroke, thrombolysis
inTrODUcTiOn
The site of arterial occlusion represents one of the most important factors determining outcome after 
anterior circulation ischemic stroke (1, 2). However, relatively little is known regarding outcome 
predicting variables in patients with distal middle cerebral artery (MCA) occlusion.
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The Alberta Stroke Program Early CT Score (ASPECTS) was 
introduced to provide a structured infarct size and location analy-
sis to aid clinical decision making (3). Its availability on initial 
evaluation of non-contrast head computed tomography (CT) 
makes it a relevant neuroimaging marker that does not require 
complex image post-processing. Its utility for acute treatment 
decision making in acute stroke patients with MCA occlusion 
has previously been documented (4). Specifically, stroke patients 
with a high pre-treatment ASPECTS are more likely to have a 
favorable outcome. However, because patients with distal MCA 
occlusion (M2) tend to have a high ASPECTS related to the spar-
ing of subcortical tissues (5–7), a more granular understanding 
of the association of the ASPECTS with outcome in these patients 
is needed.
A better understanding of this issue is highlighted by the trans-
formative results from the recent positive endovascular stroke tri-
als (2, 4, 8–10). However, less than 3% of enrolled patients had an 
isolated M2 occlusion and the majority of patients experience a 
favorable outcome irrespective of endovascular therapy (4, 7, 11). 
Hence, identifying imaging parameters that predict poor out-
come in this population may aid in the proper patient selection 
for therapy.
Therefore, we sought to determine whether information 
regarding infarct location encoded in the ASPECTS allows for 
defining patients at high risk for a poor functional outcome after 
isolated M2 occlusion in addition to the total ASPECTS score. We 
hypothesized that infarction in distinct ASPECTS location will be 
associated with a poor outcome.
MaTerials anD MeThODs
study sample
We performed a retrospective analysis of consecutive acute 
ischemic stroke patients admitted to a single academic center 
from January 2010 to August 2012. Only patients with isolated M2 
occlusion on admission CT-angiography (CTA) were included. 
This study was approved by the Institutional Review Board of 
the University of Massachusetts Medical School. Because this 
was a retrospective analysis the consent requirement was waived. 
Included patients have been described as part of a prior study (12).
All patients had head CT performed on presentation to the 
emergency room. Patient demographics, comorbidities, pre-
admission medications, laboratory data, treatment modality 
[conservative management versus acute intervention (intrave-
nous thrombolysis and endovascular recanalization)], and stroke 
etiology (according to the Trial of Org 10172 in Acute Stroke 
Treatment classification) (13) after completion of diagnostic 
evaluation, were collected on all patients. Admission National 
Institutes of Health Stroke Scale and modified Rankin Scale 
(mRS) scores were assessed at the time of presentation and at 
90 days by a stroke-trained physician or study nurse certified in 
the mRS (12). Good outcome at 90 days was defined as mRS ≤2.
neuroimaging Protocol
All CT sequences were obtained on a 64-row detector Philips 
scanner. NCCT was performed in a non-helical mode at 120 KvP 
and 200 mA with data reconstruction at 5 mm axial slices. CTA 
was performed using 64 mm × 0.625 mm detector configuration 
with a pitch of 0.673, from the arch of aorta to the vertex using 
120  KvP, 300  mA, and 0.5-s rotation time. Patients received 
60–80  mL of Isovue 370 (Bracco Diagnostics, Princeton, NJ, 
USA) in the antecubital vein at a rate of 4  mL/s through a 
power injector followed by 40  mL saline. Three-dimensional 
orthogonal maximum intensity projection images were created 
in three planes.
image review and analysis
Image review and analysis has been described in detail earlier 
(12). Briefly, CT and CTA were reviewed independently by study 
physicians masked to clinical data, follow-up scans, patient vari-
ables, and outcomes. The M2 segment was defined as the segment 
extending from the bifurcation/trifurcation of the MCA to the 
top of the Sylvian fissure to further division (12). For the purpose 
of this study, we performed an infarct location analysis on the 
initial head CT as defined by ASPECTS system (3). These areas 
included the insula (I), caudate nucleus (C), lentiform nucleus 
(L), internal capsule (IC), superior parietal lobe (M6), precen-
tral and superior frontal lobe (M5), anterior superior frontal 
lobe (M4), inferior parietal and posterior temporal lobe (M3), 
temporal lobe (M2), and anterior inferior frontal lobe (M1) (14). 
Scoring was conducted by an experienced reader (Muhib Khan) 
trained in ASPECTS (http://www.aspectsinstroke.com).
statistical Methods
All analyses were conducted using SAS Software 9.4 (SAS 
Inc., Cary, NC, USA). Poor outcome (mRS 3–6) was modeled 
with ASPECTS score using multivariable logistic regression, 
both as an ordinal measure and dichotomized >6 versus ≤6. 
Discriminant function analysis (DFA) was used to derive a single 
statistical function from all ASPECTS regions that distinguishes 
between a poor and favorable outcome; ASPECT regions were 
then evaluated by how well each region correlated with the 
derived discriminant function distinguishing between a poor 
and favorable outcome. DFA was used as it is more robust than 
multivariable logistic regression for small sample sizes. DFA was 
produced using the CANDISC procedure. In order to confirm 
and quantify the relationship between each region and outcome, 
logistic regression was used to model the relationship between 
each individual ASPECT region with poor outcome using the 
LOGISTIC procedure; odds ratios (OR) (effect size), c-statistics 
[area under the receiver operating characteristics curve (AUC)], 
and Akaike information criterion (AIC) (AIC-relative model fit) 
values were, therefore, estimated for each region. In addition, 
sensitivity, specificity, as well as positive and negative predictive 
values and likelihood ratios were determined for each ASPECTS 
region predicting poor outcome using generalized estimating 
equations (GEE), which allowed multiple observations (regions) 
to be nested within patients, using the GLIMMIX procedure. 
Group differences examined in Table  1 were compared using 
the χ2-square test or Wilcoxon test. A two sided p < 0.05 (when 
applicable) was considered significant and all estimates were 
calculated for 95% confidence interval (95% CI).
TaBle 1 | Baseline characteristics (unadjusted) of the patient sample as 
stratified by alberta stroke Program early cT score (asPecTs).
characteristics asPecTs ≤6 
(n = 24)
asPecTs >6 
(n = 66)
p-Value
Age, years (IQR) 79.5 (67–85.5) 75.5 (62–85) 0.430
Female (%) 66.7 51.5 0.200
Admission NIHSS (IQR) 16 (6–24) 7 (4–10) 0.009
i.v. rtPA (%) 21 27 0.536
Hypertension (%) 71 82 0.259
Dyslipidemia (%) 46 61 0.211
Diabetes (%) 25 38 0.255
Prior stroke or TIA (%) 13 15 0.751
Atrial fibrillation (%) 29 32 0.810
IQR, interquartile range, i.v., intravenous; mRS, modified Rankin Scale; NIHSS, National 
Institutes of Health Stroke Scale; PH, parenchymal hemorrhage Type 1 and 2; rtPA, 
recombinant tissue plasminogen activator; TIA, transient ischemic attack.
TaBle 2 | Discriminate function analysis, prediction, and performance of individual alberta stroke Program early cT score region infarction indicative 
of a poor outcome.
area Discriminant function Prediction Performance
loading Beta Or 95% ci aUc 95% ci aic p
right
M1 0.15 0.22 1.97 (0.36–10.82) 0.56 (0.40–0.71) 47.72 0.4358
M2 0.43 0.51 5.54 (1.20–25.68) 0.70 (0.53–0.87) 43.19 0.0286
M3 0.93 0.93 115 (9.32–na) 0.91 (0.81–1.00) 23.12 0.0002
M4 −0.07 0.05 0.70 (0.12–4.20) 0.53 (0.38–0.68) 48.16 0.6998
M5 0.35 0.04 4.00 (0.85–18.84) 0.66 (0.49–0.83) 44.95 0.0795
M6 0.66 0.40 25.7 (2.76–239.81) 0.81 (0.69–0.94) 34.87 0.0044
C 0.02 0.36 1.15 (0.09–14.19) 0.51 (0.40–0.61) 48.30 0.9132
IC 0.02 0.09 1.15 (0.09–14.19) 0.51 (0.40–0.61) 48.30 0.9132
L 0.03 0.45 1.17 (0.18–7.56) 0.51 (0.37–0.65) 48.29 0.8715
Insula 0.06 0.21 1.25 (0.30–5.23) 0.53 (0.34–0.71) 48.22 0.7599
left
M1 −0.19 −0.28 – – 0.53 (0.50–0.57) 57.18 0.9728
M2 0.27 0.22 2.43 (0.62–9.56) 0.61 (0.44–0.78) 56.91 0.2038
M3 0.77 0.69 14.90 (2.75–80.29) 0.79 (0.66–0.93) 45.61 0.0017
M4 −0.19 0.00 – – 0.53 (0.50–0.57) 57.18 0.9728
M5 0.59 0.63 12.63 (1.48–107.53) 0.73 (0.62–0.85) 49.76 0.0203
M6 0.66 0.26 10.40 (1.97–54.87) 0.76 (0.62–0.90) 48.73 0.0059
C −0.22 −0.32 – – 0.55 (0.50–0.59) 56.69 0.9685
IC −0.30 0.18 – – 0.58 (0.53–0.58) 55.14 0.9581
L −0.19 0.18 0.38 (0.04–3.35) 0.56 (0.45–0.67) 57.66 0.3821
Insula −0.16 −0.09 0.60 (0.16–2.27) 0.56 (0.39–0.73) 58.02 0.4524
Loading and beta coefficients derived from discriminant function analysis, where stronger positive values relate to the function of poor outcome. Odds ratios (ORs), area under 
the receiver operating characteristics curve (AUC), and Akaike information criterion (AIC) are derived from logistic regression modeling, which estimate size of effect, diagnostic 
performance, and model fit, respectively.
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resUlTs
Overall, 90 patients with isolated M2 occlusions were included 
for analysis. Among these, 66 (73%) patients had an ASPECTS 
of >6 and the majority of patients (69%) had a good 90-day out-
come. Baseline characteristics of included patients as stratified by 
ASPECTS ≤6 versus >6 (15) are summarized in Table 1.
The mean ASPECTS score was 7.1, 95% CI 6.8–7.4. An 
ASPECTS score ≤6 was associated with poor outcome (sensitiv-
ity =  0.591, specificity =  0.838, p <  0.001). Logistic regression 
analysis indicated that for every unit decrease in ASPECTS score, 
the odds of poor outcome increased more than twofold (OR: 2.32, 
95% CI 1.50–3.59, AUC =  0.799, p <  0.001). We then sought 
to determine whether distinct infarct regions encoded by the 
ASPECTS allow for defining patients at risk for a poor functional 
outcome. Because more than one ASPECTS region was fre-
quently infarcted in a given patient, DFA was used to model the 
relationship of region on poor outcome. Table 2 summarizes each 
region’s relationship with poor outcome derived from the DFA 
whereby larger loading and coefficient values indicate a stronger 
relationship with the statistically derived discriminant function 
that distinguished between and poor and favorable outcome. In 
particular, infarction in M3 had the strongest relationship with 
the discriminant function relative to all other regions, followed by 
M6. The relationship with each region, alone, was then quantified 
using logistic regression, which indicated that infarction in M3 
and M6 had statistically significant and relatively large OR (right 
M3 =  115, left M3 =  14.9, right M6 =  25.7, left M6 =  10.4), 
indicating a relationship with poor outcome. Moreover, infarc-
tion in M3 and M6 had the largest AUCs indicating superior 
discrimination between good and poor outcomes, relative to 
all other areas. M3 and M6 also had the smallest AIC values, 
indicating that models of poor outcome using M3 and M6 were 
superior to models using other ASPECTS encoded regions, i.e., 
the combined analysis with logistic regression and DFA indicates 
that infarction in cortical M3 and adjacent M6 ASPECTS regions 
on either side are the strongest predictors of a poor outcome after 
M2 occlusion. Infarction in the left M5, right M2, and right M5 
should also be considered as indicators of poor outcome as they 
were statistically significant or approached significance relative 
to the remaining regions.
TaBle 3 | sensitivity, specificity, positive and negative predictive values, 
and likelihood ratios of individual alberta stroke Program early cT score 
region infarction for poor outcome (mrs >2).
area sensitivity specificity PPV nPV +lr −lr
right
M1 0.27 0.84 0.43 0.72 1.70 0.87
M2 0.64 0.76 0.54 0.83 2.65 0.48
M3 0.91 0.92 0.83 0.96 11.36 0.10
M4 0.18 0.76 0.25 0.68 0.76 1.08
M5 0.73 0.60 0.44 0.83 1.82 0.45
M6 0.91 0.72 0.59 0.95 3.25 0.13
C 0.09 0.92 0.33 0.70 1.14 0.99
Internal capsule (IC) 0.09 0.92 0.33 0.70 1.14 0.99
L 0.18 0.84 0.33 0.70 1.14 0.97
Insula 0.46 0.60 0.33 0.71 1.15 0.90
left
M1 0.00 0.93 0.00 0.78 0.00 1.08
M2 0.64 0.58 0.28 0.86 1.52 0.63
M3 0.82 0.77 0.47 0.94 3.52 0.24
M4 0.00 0.93 0.00 0.78 0.00 1.08
M5 0.91 0.56 0.34 0.96 2.06 0.16
M6 0.82 0.70 0.41 0.94 2.71 0.26
C 0.00 0.90 0.00 0.78 0.00 1.11
IC 0.00 0.84 0.00 0.76 0.00 1.19
L 0.09 0.80 0.10 0.77 0.45 1.14
Insula 0.46 0.42 0.17 0.75 0.79 1.29
PPV, positive predictive value; NPV, negative predictive value; +LR, positive likelihood 
ratio; −LR, negative likelihood ratio.
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Last, each region was evaluated for diagnostic performance of 
poor outcome. Using GEE, we found that M3, M5, and M6 for 
both the right and the left had a high sensitivity and specificity 
(p < 0.01) for predicting a poor outcome (Table 3). Specifically, 
infarction in right M3 region was highly sensitive (0.91) and 
specific (0.92) of poor outcome.
DiscUssiOn
The most important findings of our study are that infarction in 
the M3 and M6 ASPECTS region predict a poor outcome after 
isolated M2 occlusion. We and others have previously shown that 
a substantial minority of patients with M2 occlusion have a poor 
outcome by 3 months (7, 11, 12, 16). Our results show that the 
anatomical and geometric information of the ASPECTS allows 
for more specific identification of patients at high risk for poor 
outcome after isolated M2 occlusion.
The ASPECTS template for anatomical lesion mapping 
within the MCA territory has the advantage that it does 
not require elaborate volumetric image analysis and allows 
for identifying patients likely to have a poor outcome in the 
emergency setting (4, 17, 18). The dichotomized ASPECTS 
score has been used to predict outcome in earlier studies, which 
found an ASPECTS greater than 6 to 7 to be predictive of 
good outcome (3, 4, 17, 19). Recent multicenter cohort of M2 
occlusion patients undergoing thrombectomy also showed that 
ASPECTS ≥6 predicts a good outcome (7). Consistent with 
these prior results, we found that ASPECTS ≥6 predicted a 
good outcome.
Using DFA, we found that in our sample, infarction in M3 
and M6 locations were most predictive of a poor outcome. This 
is not too surprising because even relatively small infarcts in the 
M3 region (which includes the language centers located within 
the inferior parietal and posterior temporal lobes) and M6 region 
(which includes the primary motor cortex) may cause significant 
disability (20, 21) related to ensuing motor deficits and aphasia 
(22, 23). Of note, though infarction of subcortical structures such 
as lentiform nucleus and IC have been identified as predictors of 
outcome (20, 24, 25), we did not find such an association in our 
study. However, this discrepancy may be explained by the fact 
that our study was underpowered to detect such an association 
due to low number of patients with a subcortical infarction. It is 
possible that subcortical infarction occurred mostly in patients 
who originally had an occlusion of the M1-segment of the MCA 
[which gives rise to the lenticulostriate arteries to supply the stria-
tocapsular region (26, 27)] and then subsequent clot migration 
to the M2 segment [which predominantly supplies the cerebral 
cortex and adjacent white matter (26–28)] by the time of CTA.
We did not find any effect on outcome based on hemispheric 
laterality of stroke. Earlier studies have shown an impact of 
hemispheric laterality on functional outcomes after ischemic 
stroke (29–32). We feel that smaller infarct volume and neglect 
might have played a role in minimizing the effect of lateralization. 
Further study is required to determine the effects of lesion lateral-
ity and the impact on stroke outcome. Endovascular therapy in 
these patients has recently been shown to improve outcomes (7). 
Therefore, further research is needed using an external stroke 
cohort evaluating our findings to improve patient selection 
for this particular group. We envision the development of an 
imaging index that incorporates assessments of ischemic core 
volumes and location in conjunction with markers of collateral 
and perfusion status. Such an index will allow for accurate and 
rater unbiased selection of patients for emergent recanalization 
therapies for M2 occlusion.
The strengths of our study relate to the analysis of a well-
defined patient population based on advanced intracranial 
vascular imaging. We utilized multiple statistical methods in a 
stepwise fashion to identify the ASPECTS regions, which predict 
outcomes in this population. The collection of a large number of 
clinically relevant variables contributed to improved data quality 
while limiting the potential for misclassification. Limitations of 
our study relate to its retrospective design and relatively small 
sample size. However, to account for the low sample size, we 
used DFA instead of logistic regression alone. Williams and Titus 
found that, as a general rule, sample size should be about 3xP 
variables [in our case p  =  10, for each group (30)] (33). In 
addition to mitigate the risk of DFA-related model overfitting, 
we also provided the results of simple logistic regression as well 
as repeated measures logistic regression with modeling of the 
different ASPECTS regions within each patient. Importantly, 
our models were stable as indicated by the consistent results 
across model solutions (sensitivity, specificity, loadings, odds 
ratio, area under the receiver operator characteristics curve, AIC, 
and p-Values). Further, diagnostic and therapeutic modalities 
were used at the treating stroke physician’s discretion, which 
may have introduced bias. Moreover, non-contrast CT head was 
used to determine ASPECTS, which might be less sensitive than 
newer imaging modalities. Our findings require confirmation 
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in further, prospective studies and should only be considered 
hypothesis generating.
cOnclUsiOn
In conclusion, this study shows that infarct topography as defined 
by ASPECTS allows for prediction of functional outcome after 
M2 occlusion. These findings may be helpful for stratifying 
outcomes if validated in other studies.
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